脂质纳米颗粒的进化:为下一代核酸药物铺平道路
Xuan Lin1, Hongguang Xiang1, Jiong Wu1
1Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
Asian journal of pharmaceutical sciences
|March 11, 2026
概括
脂质纳米颗粒 (LNP) 对于提供核酸疗法至关重要,克服了吸收和降解不良等挑战. 本综述探讨了LNP在有效基因表达调节和疾病治疗方面的进展.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 分子疗法 分子疗法
背景情况:
- 核酸疗法为治疗各种疾病提供了潜力,但面临着交付挑战.
- 局限性包括高分子量,细胞吸收不良和酶降解in vivo.
- 病毒和非病毒载体,如脂质纳米粒子 (LNP),已被开发来解决这些问题.
研究的目的:
- 审查核酸药物载体的关键作用.
- 概述当前的运营商,并研究基于LNP的系统的进步.
- 澄清LNP如何克服交付障碍,并将其与其他运营商进行比较.
主要方法:
- 审查最近在LNP设计和交付机制的进展.
- 基于LNP的核酸输送的临床应用的分析.
- 对LNP与其他交付载体进行比较评估.
主要成果:
- 脂质纳米粒子 (LNP) 显示出优异的生物相容性,高的传递效率和设计灵活性.
- 临床上,LNP已经取得了成功,siRNA药物Onpattro®就是一个很好的例子.
- 在核酸输送过程中,LNP有效地克服了常见的障碍.
结论:
- 脂质纳米粒子 (LNP) 是核酸疗法的领先平台.
- 在LNP设计的持续进步是下一代治疗的关键.
- 了解LNP机制和应用对于未来的治疗开发至关重要.
相关概念视频
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.